HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activation

Blood

Volumn 119, Issue 10, 2012, Pages 2274-2283

  Giagulli, Cinzia ^a   Magiera, Anna K ^a   Bugatti, Antonella ^a   Caccuri, Francesca ^a   Marsico, Stefania ^b   Rusnati, Marco ^a   Vermi, William ^a   Fiorentini, Simona ^a   Caruso, Arnaldo ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF CALABRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CXCR1; INTERLEUKIN 8; INTERLEUKIN 8 RECEPTOR; LIGAND; MATRIX PROTEIN; PROTEIN KINASE; PROTEIN P17; PROTEIN ROCK; RHO FACTOR; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL ADHESION; CHEMOTAXIS; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOCOMPETENT CELL; LEUKEMIA CELL LINE; MONOCYTE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SURFACE PLASMON RESONANCE; VIRUS REPLICATION;

EID: 84858035209     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-06-364083     Document Type: Article

References (50)

1. Fischer-Smith T, Croul S, Sverstiuk AE, et al. CNS invasion by CD14+/CD16- peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection. J Neurovirol. 2001;7(6):528-541. (Pubitemid 34041054)
2. Price P, Mathiot N, Krueger R, et al. Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy. J Clin Virol. 2001;22(3):279-287. (Pubitemid 32846559)
3. Gallo RC. Tat as one key to HIV-induced immune pathogenesis and Tat toxoid as an important component of a vaccine. Proc Natl Acad Sci U SA. 1999;96(15):8324-8326. (Pubitemid 29354785)
4. Simmons A, Aluvihare V, McMichael A. Nef triggers a transcriptional program in T cells imitating single-signal T cell activation and inducing HIV virulence mediators. Immunity. 2001;14(6):763-777. (Pubitemid 32592423)
5. Fiorentini S, Riboldi E, Facchetti F, et al. HIV-1 matrix protein p17 induces human plasmacytoid dendritic cells to acquire a migratory immature cell phenotype. Proc Natl Acad Sci U S A. 2008; 105(10):3867-3872. (Pubitemid 351723491)
6. Budka H. Human immunodeficiency virus (HIV) envelope and core proteins in CNS tissues of patients with the acquired immune deficiency syndrome (AIDS). Acta Neuropathol. 1990;79(6): 611-619. (Pubitemid 20170337)
7. Popovic MTenner-Racz K, Pelser C, et al. Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy. Proc Natl Acad Sci U S A. 2005;102(41):14807-14812.
8. Fiorentini S, Giagulli C, Caccuri F, Magiera AK, Caruso A. HIV-1 matrix protein p17: a candidate antigen for therapeutic vaccines against AIDS. Pharmacol Ther. 2010;128(3):433-444.
9. De Francesco MA, Baronio M, Fiorentini S, et al. HIV-1 matrix protein p17 increases the production of proinflammatory cytokines and counteracts IL-4 activity by binding to a cellular receptor. Proc Natl Acad Sci U S A. 2002;99(15):9972-9977. (Pubitemid 34831157)
10. Marini E, Tiberio L, Caracciolo S, et al. HIV-1 matrix protein p17 binds to monocytes and selectively stimulates MCP-1 secretion: role of transcriptional factor AP-1. Cell Microbiol. 2008;10(3): 655-666. (Pubitemid 351194093)
11. Giagulli C, Marsico S, Magiera AK, et al. Opposite effects of HIV-1 p17 variants on PTEN activation and cell growth in B cells. PLoS One. 2011;6(3): e17831.
12. Honing H, van den Berg TK, van der Pol SM, et al. RhoAactivation promotes transendothelial migration of monocytes via ROCK. J Leukoc Biol. 2004;75(3): 523-528. (Pubitemid 38316384)
13. Amano M, Chihara K, Kimura K, et al. Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase. Science. 1997;275(5304): 1308-1311. (Pubitemid 27114159)
14. Caruso A, Favilli F, Rotola A, et al. Human herpesvirus-6 modulates RANTES production in primary human endothelial cell cultures. J Med Virol. 2003;70(3):451-458. (Pubitemid 36638060)
15. Fontana L, Giagulli C, Minuz P, Lechi A, Laudanna C. 8-Iso-PGF2 alpha induces beta 2-integrin-mediated rapid adhesion of human polymorphonuclear neutrophils: a link between oxidative stress and ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol. 2001;21(1):55-60. (Pubitemid 32061927)
16. Navratilova I, Dioszegi M, Myszka DG. Analyzing ligand and small molecule binding activity of solubilized GPCRs using biosensor technology. Anal Biochem. 2006;355(1):132-139. (Pubitemid 44041399)
17. Khalifa MB, Choulier L, Lortat-Jacob H, Altschuh D, Vernet T. BIACORE data processing: an evaluation of the global fitting procedure. Anal Biochem. 2001; 293(2):194-203. (Pubitemid 32547904)
18. Campbell JJ, Qin S, Bacon KB, et al. Biology of chemokine and classical chemoattractant receptors: differential requirements for adhesion-triggering versus chemotactic responses in lymphoid cells. J Cell Biol. 1996;134(1):255-66. (Pubitemid 26231535)
19. Poiesi C, De Francesco MA, Baronio M, Manca N. HIV-1 p17 binds heparan sulfate proteoglycans to activated CD4() T cells. Virus Res. 2008;132(1-2): 25-32. (Pubitemid 351232079)
20. Sozzani S, Luini W, Molino M, et al. The signal transduction pathway involved in the migration induced by a monocyte chemotactic cytokine. J Immunol. 1991;147(7):2215-2221.
21. Schilling T, Eder C. Lysophosphatidylcholine- and MCP-1-induced chemotaxis of monocytes requires potassium channel activity. Pflugers Arch. 2009;459(1):71-7.
22. Struckhoff AP, Vitko JR, Rana MK, et al. Dynamic regulation of ROCK in tumor cells controls CXCR4-driven adhesion events. J Cell Sci. 2010; 123(Pt3):401-412.
23. Worthylake RA, Burridge K. RhoA and ROCK promote migration by limiting membrane protrusions. J Biol Chem. 2003;278(15):13578-13584. (Pubitemid 36800134)
24. Gerszten REGarcia-Zepeda EA, Lim YC, et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature. 1999;398(6729):718-723.
25. Hammond ME, Lapointe GR, Feucht PH, et al. IL-8 induces neutrophil chemotaxis predominantly via type I IL-8 receptors. J Immunol. 1995; 155(3):1428-1433.
26. Schraufstatter IU, Chung J, Burger M. IL-8 activates endothelial cell CXCR1 and CXCR2 through Rho and Rac signaling pathways. Am J Physiol Lung Cell Mol Physiol. 2001;280(6): L1094-L1103.
27. Loetscher P, Seitz M, Clark-Lewis I, Baggiolini M, Moser B. Both interleukin-8 receptors independently mediate chemotaxis. Jurkat cells transfected with IL-8R1 or IL-8R2 migrate in response to IL-8, GRO alpha and NAP-2. FEBS Lett. 1994; 341(2-3):187-192. (Pubitemid 24102679)
28. Rich RL, Errey J, Marshall F, Myszka DG. Biacore analysis with stabilized G-protein-coupled receptors. Anal Biochem. 2011;409(2):267-272.
29. Fernando H, Chin C, Rosgen J, Rajarathnam K. Dimer dissociation is essential for interleukin-8 (IL-8) binding to CXCR1 receptor. J Biol Chem. 2004;279(35):36175-36178. (Pubitemid 39128951)
30. Jones SA, Wolf M, Qin S, Mackay CR, Baggiolini M. Different functions for the interleukin 8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2. Proc Natl Acad Sci U S A. 1996;93(13):6682-6686. (Pubitemid 26230369)
31. Guichard C, Pedruzzi E, Dewas C, et al. Interleukin-8-induced priming of neutrophil oxidative burst requires sequential recruitment of NADPH oxidase components into lipid rafts. J Biol Chem. 2005;280(44):37021-37032. (Pubitemid 41587786)
32. Hammond ME, Shyamala V, Siani MA, et al. Receptor recognition and specificity of interleukin-8 is determined by residues that cluster near a surface-accessible hydrophobic pocket. J Biol Chem. 1996;271(14):8228-8235. (Pubitemid 26108654)
33. Rajagopalan L, Rajarathnam K. Ligand selectivity and affinity of chemokine receptor CXCR1. Role of N-terminal domain. J Biol Chem. 2004;279(29): 30000-30008. (Pubitemid 38937920)
34. Fiorentini S, Marini E, Bozzo L, et al. Preclinical studies on immunogenicity of the HIV-1 p17-based synthetic peptide AT20-KLH. Biopolymers. 2004;76(4):334-343. (Pubitemid 39468256)
35. Shoemaker BA, Portman JJ, Wolynes PG. Speeding molecular recognition by using the folding funnel: the fly-casting mechanism. Proc Natl Acad Sci U S A. 2000;97(16):8868-8873. (Pubitemid 30626639)
36. Ahuja SK, Murphy PM. The CXC chemokines growth-regulated oncogene (GRO) alpha, GRO-beta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. J Biol Chem. 1996;271(34):20545-20550. (Pubitemid 26281830)
37. Liu Y, de Waal Malefyt R, Briere F, et al. The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor. J Immunol. 1997;158(2):604-613. (Pubitemid 127492636)
38. Tzahar E, Yarden Y. The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligands. Biochim Biophys Acta. 1998;1377(1):M25-37. (Pubitemid 28144426)
39. De Francesco MA, Baronio M, Poiesi C. HIV-1 p17 matrix protein interacts with heparan sulfate side chain of CD44v3, syndecan-2, and syndecan-4 proteoglycans expressed on human activated CD4+T cells affecting tumor necrosis factor alpha and interleukin 2 production. J Biol Chem. 2011;286(22):19541- 19548.
40. Hoogewerf AJ, Kuschert GS, Proudfoot AE, et al. Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry. 1997; 36(44):13570-13578. (Pubitemid 27481603)
41. Wain LV, Bailes E, Bibollet-Ruche F, et al. Adaptation of HIV-1 to its human host. Mol Biol Evol. 2007;24(8):1853-1860. (Pubitemid 47236708)
42. Vasilescu A, Terashima Y, Enomoto M, et al. A haplotype of the human CXCR1 gene protective against rapid disease progression in HIV-1+ patients. Proc Natl Acad Sci U S A. 2007;104(9): 3354-3359. (Pubitemid 46364163)
43. De Francesco MA, Caruso A, Fallacara F, et al. HIV p17 enhances lymphocyte proliferation and HIV-1 replication after binding to a human serum factor. AIDS. 1998;12(3):245-252. (Pubitemid 28045452)
44. Matsumoto T, Miike T, Nelson RP, Trudeau WL, Lockey RF, Yodoi J. Elevated serum levels of IL-8 in patients with HIV infection. Clin Exp Immunol. 1993;93(2):149-151. (Pubitemid 23238018)
45. Meddows-Taylor S, Martin DJ, Tiemessen CT. Dysregulated production of interleukin-8 in individuals infected with human immunodeficiency virus type 1 and Mycobacterium tuberculosis. Infect Immun. 1999;67(3):1251-1260. (Pubitemid 29108502)
46. Lane BR, Lore K, Bock PJ, et al. Interleukin-8 stimulates human immunodeficiency virus type 1 replication and is a potential new target for antiretroviral therapy. J Virol. 2001;75(17):8195-8202. (Pubitemid 32743692)
47. Zheng JC, Huang Y, Tang K, et al. HIV-1-infected and/or immune-activated macrophages regulate astrocyte CXCL8 production through IL-1beta and TNF-alpha: involvement of mitogen-activated protein kinases and protein kinase R. J Neuroimmunol. 2008;200(1-2):100-110.
48. Esser R, Glienke W, von Briesen H, Rübsamen-Waigmann H, Andreesen R. Differential regulation of proinflammatory and hematopoietic cytokines in human macrophages after infection with human immunodeficiency virus. Blood. 1996; 88(9):3474-3481. (Pubitemid 26365582)
49. Kutsch O, Oh J, Nath A, Benveniste EN. Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes. J Virol. 2000;74(19):9214-9221.
50. Ginestier C, Liu S, Diebel ME, et al. CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J Clin Invest. 2010;120(2):485-497.